# Early Versus Conventional Cessation of Hydrocortisone in Septic Shock

> **NCT05818826** · PHASE2 · UNKNOWN · sponsor: **Mahidol University** · enrollment: 160 (estimated)

## Conditions studied

- Septic Shock
- Adverse Event
- Hydrocortisone
- Hyperglycemia
- Hypernatremia
- Muscle Weakness
- Superimposed Infection

## Interventions

- **DRUG:** normal saline solution
- **DRUG:** Hydrocortisone and normal saline solution

## Key facts

- **NCT ID:** NCT05818826
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-05
- **Primary completion:** 2025-04
- **Final completion:** 2025-05
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2024-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05818826

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05818826, "Early Versus Conventional Cessation of Hydrocortisone in Septic Shock". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05818826. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*